Table 4.

Peri-operative summary

Patient	Duration of surgery (minutes)	Intra-op deficits or complication	Post-op deficits	Post-op stay	HPE	Residual tumour	Progress and outcome
1	170	nil	nil	5 days	Cavernous angioma	No	Well and asymptomatic
2	205	nil	Right upper limb monoparesis	13 days	Oligodendroglioma WHO Grade 2	Yes	On surveillance-persistent right upper limb weakness
3	130	nil	nil	7 days	Diffuse astrocyctoma WHO Grade 2	No	On surveillance
4	190	Brain swelling	nil	8 days	Anaplastic astrocytoma WHO Grade 3	Yes	Debulking under GA for recurrence. Passed away after 1 year
5	250	nil	nil	3 days	Diffuse astrocytoma WHO Grade 2	No	On surveillance-seizure free
6	150	Left sided body weakness and dysphasia	Left upper limb monoparesis and dysphasia	5 days	Oligodendroglioma WHO Grade 2	No	On surveillance-resolved weakness and speech deficit
7	265	Right finger weakness	Right finger flexion weakness	2 days	Diffuse astrocytoma WHO Grade 2	No	On surveillance-resolved weakness
8	160	nil	nil	10 days	Metastatic adenocarcinoma	No	Underwent WBRT
9	330	nil	nil	3 days	Oligodendroglioma WHO Grade 2	No	On surveillance-Seizure free
10	280	nil	nil	6 days	Glioblastoma WHO Grade 4	Yes	Refused chemotherapy and radiotherapy
11	270	nil	nil	7 days	High grade glioma WHO Grade 3	Yes	Completed chemotherapy and radiotherapy-on surveillance